Ignite Creation Date:
2025-12-25 @ 12:54 AM
Ignite Modification Date:
2025-12-25 @ 11:09 PM
Study NCT ID:
NCT05878067
Status:
COMPLETED
Last Update Posted:
2024-10-15
First Post:
2023-05-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-06
Completion Date Type:
ACTUAL
First Submit Date:
2023-05-24
First Submit QC Date:
None
Study First Post Date:
2023-05-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-23
Results First Submit QC Date:
None
Results First Post Date:
2024-10-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-23
Last Update Post Date:
2024-10-15
Last Update Post Date Type:
ACTUAL